Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
The tables based on the NICE (National Institute for Health and Care Excellence) guidelines for the management of type 2 diabetes provide a structured approach to escalating therapy in individuals with this condition. The central tenet of these guidelines is the gradual intensification of treatment to optimize blood glucose control while minimizing side effects, especially hypoglycemia and weight gain. This approach recognizes the progressive nature of type 2 diabetes and the need for individualized treatment strategies.
Let us review the key changes of the updates in June 2022
| Key Update | Details | References |
|---|---|---|
| Expanded Role of SGLT2 Inhibitors & GLP-1 Receptor Agonists | These medications should be considered earlier in treatment, particularly for patients with cardiovascular disease or high cardiovascular risk, due to their cardiovascular benefits. | Basudev (2022), McEwan et al. (2023) |
| Integrated Approach & Self-Management Education | Stronger emphasis on structured self-management education programs, which improve glycemic control and reduce hospital admissions. Tailoring interventions based on social determinants of health and health literacy is also highlighted. | Yüksel et al. (2023), Salinas-MartÃnez et al. (2023), Nield (2023), Debussche et al. (2022) |
| Continuous Glucose Monitoring (CGM) | Recommended for patients on insulin therapy who experience problematic hypoglycemia or unstable blood glucose levels, enhancing patient safety... |
Try our Free Plan to get the full article.
